Clinical Report: At the Show - Day 2

Overview

The 2025 Global Specialty Lens Symposium highlights advancements in myopia management, emphasizing the efficacy of dual-focus soft contact lenses and orthokeratology. Recent studies reinforce the importance of individualized treatment approaches and proactive monitoring.

Background

Myopia management is a critical area of focus in ophthalmology, particularly with the rising prevalence of myopia in children. The 2025 Global Specialty Lens Symposium serves as a platform for sharing the latest research and clinical practices in specialty lens fitting. Understanding the efficacy and safety of various optical interventions is essential for optimizing patient outcomes.

Data Highlights

No numerical data was presented in this article.

Key Findings

• The International Myopia Institute recommends proactive, individualized myopia management strategies.
• Dual-focus soft contact lenses and orthokeratology have shown sustained efficacy without rebound effects after treatment cessation.
• Recent trials indicate that the myopia-control effect of orthokeratology remains stable over three years.
• Smaller back optic zone diameters in orthokeratology lenses are associated with greater axial-length slowing.
• A multicenter RCT demonstrated that daily-disposable defocus-incorporated soft lenses significantly slowed myopia progression compared to single-vision lenses.

Clinical Implications

Clinicians should consider incorporating dual-focus soft contact lenses and orthokeratology into their myopia management protocols. Regular monitoring and individualized treatment plans are crucial for optimizing patient outcomes in myopia control.

Conclusion

The findings presented at the symposium underscore the importance of evidence-based approaches in myopia management. Continued research and clinical collaboration will enhance the effectiveness of specialty lenses in treating myopia.

References

1. Contact Lens Spectrum, 2025 -- At the Show - Day 1
2. Contact Lens Spectrum, 2025 -- At the Show - Day 3
3. Contact Lens Spectrum, 2026 -- At the Show
4. IMI 2025 Digest -- Myopia Management Recommendations
5. CONTROL2 Study -- Myopia Control with Orthokeratology
6. Eyecare Business — EB Premieres “Flaunt the Frame” Fashion Show Series at Vision Expo West
7. Eyecare Business -- EB Premieres “Flaunt the Frame” Fashion Show Series
8. IMI 2025 Digest
9. Myopia control with orthokeratology lenses. A 3-year follow-up study including a cross-over design: Clinical study Of Near-sightedness; TReatment with Orthokeratology Lenses 2 (CONTROL2 study) - PubMed
10. Scleral lens landing zone toricity and tear exchange - ScienceDirect